Emtora Biosciences

Biotechnology, Health Care, Life Science, Manufacturing, Pharmaceutical
Founded in 1/1/12
San Antonio, Texas, United States
http://www.emtorabio.com/
For Profit

About Emtora Biosciences

Emtora Biosciences is a life science company that commercializes a new formulation of an immunosuppressant as a prostate cancer drug. The company developing a novel formulation of rapamycin, eRapa for use in preventing the onset and recurrence of cancer. It manufactures a drug to slow the aging process and its efficacy in treating age-related diseases. The eRapa is the only pharmaceutical agent to demonstrate significantly increased healthspan and lifespan in rodent models, and Science, Nature, and Time magazines proclaimed the discovery of a special formulation of rapamycin to extend one’s life and health span among the most significant and exciting scientific breakthroughs of 2009.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 23826094 USD
  • Last Funding: 16900000 USD (Grant)
  • Funding Status: Early Stage Venture

Technology Stack

Emtora Biosciences actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Life Science, Manufacturing, Pharmaceutical

Headquarters: San Antonio, Texas, United States